The 3D Cell Culture market was valued at USD 680.25 Million in 2017 and is expected to reach at USD 3,134.25 Million by 2025 growing at a Compound annual growth rate (CAGR) of 18.5% from 2018 to 2025. Biomaterial properties has the potential to modify or restructure cell behavior through cell proliferation, shape, survival, migration and differentiation. Hence, rising application of 3D cell culture towards cell biomaterial interactions is expected to boost the demand for 3D cell culture market. In addition, increasing adoption of organ transplantation coupled with increasing research programs for tissue engineering and chronic diseases are further estimated to create new necessities and augment the market of growth over the forecast period of 2018-2025.
The 3D cell culture market has been segmented based on technology which is further divided into scaffold-based, scaffold-free and 3D bioreactor. Based on application the market has been segmented as tissue engineering, organ-on-chips, drugs discovery and testing, cancer research and others. Furthermore, the market is segmented as end-user which is sub segmented as research institutes, hospitals, pathology laboratories and others. The increasing incidence of cancer patients and high mortality rate owing to this severe disease is expected to propel the demand for more research to discover effective solutions for this disease which in turn will drive the cancer segment to adopt 3D cell culture significantly during the forecast period.
The global 3D cell culture market has been geographically segmented into Asia-Pacific, Europe, North America, Latin America, the Middle East and Africa region. In addition to this, North America region holds the largest market share. The reason may be attributed to the presence of established pharmaceutical companies and technologically upgraded research laboratories where 3D cell culture model has been adopted significantly. In addition, government grants and increased public expenditure towards healthcare sector for developing advanced medical expertise over alteration or modification of genes and cells is further estimated to be prime factor responsible for the North America to dominate the market. Asia-Pacific 3D cell culture market is expected to propel at the fastest growth rate owing to the rising investments by the key market players of North America and Europe region across the developing nations of Asia Pacific region such as China, Japan, South Korea and India. Rising incidence of patients suffering from cancer and gene disorders are expected to be the factor which will propel the 3D cell culture industry across Europe region during the forecast period.
Some of the key players in the global 3D cell culture market include 3D Biomatrix, 3D Biotek LLC, Becton Dickinson and Company, Global Cell Solutions, Inc., InSphero AG, Lonza Group, Merck, Nano3D Biosciences Corning Inc., Synthecon, Thermo Fisher Scientific and VWR International LLC.